The icd was received for analysis.Prior to the analysis of the device, the quality documents accompanying the manufacturing process for this icd were re-investigated and all production steps were performed accordingly.Particularly the final acceptance test proved the device functions to be as specified.The icd was interrogated, revealing the mos2 battery status, 129 charging cycles were recorded in the devices memory.The memory content of the icd was inspected.During the inspection, the clinical observation could be confirmed.Elevated shock impedance of up to > 150 ohms was documented in the shock holter for shocks delivered with reversed polarity on (b)(6) 2022.Besides that, the data showed no anomalies.The shock impedance measurement functions of the icd were thoroughly tested in normal and reverse polarity configuration using different temperature environments up to 50 degrees c.All measured impedances were normal and as expected.There was no indication of a malfunction.Furthermore, the ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.A fibrillation signal was applied and the device delivered a defibrillation shock as specified, documenting a normal and expected sensing and shock delivery.In particular, the specified energy level was reached and the shock impedance was as expected.In conclusion, the device was proven to be fully functional.Despite through analysis of the icd, the observed elevated shock impedances during shock delivery with reversed polarity was not reproducible.Analysis revealed no indication of a device malfunction.However, the information you provided has been entered into our quality system as a complaint and will be used to evaluate the device functionality throughout our organization and help to maintain and improve the performance of our devices.
|